Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Cholongitas, E., & Burroughs A. K. (2010).  Is it difficult to obtain an optimal liver biopsy specimen?. Hepatology. 51(1), 355-6.
Cholongitas, E., Papatheodoridis G. V., Goulis J., Vlachogiannakos J., Karatapanis S., Ketikoglou J., et al. (2015).  The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.. Ann Gastroenterol. 28(1), 109-117.
Cholongitas, E., Ioannidou M., Goulis I., Chalevas P., Ntogramatzi F., Athanasiadou Z., et al. (2017).  Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis.. J Gastroenterol Hepatol. 32(1), 191-198.
Cholongitas, E., Xirouchakis E., Garcovich M., & Burroughs A. K. (2010).  Evaluation of renal function in patients with cirrhosis.. J Hepatol. 53(3), 589.
Cholongitas, E., & Ioannidou D. (2009).  Acrocyanosis due to cold agglutinins in a patient with rheumatoid arthritis.. J Clin Rheumatol. 15(7), 375.
Cholongitas, E., Goulis J., Akriviadis E., & Papatheodoridis G. V. (2011).  Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.. Liver Transpl. 17(10), 1176-90.
Cholongitas, E., Calvaruso V., Senzolo M., Patch D., Shaw S., O'Beirne J., et al. (2009).  RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit.. J Gastroenterol Hepatol. 24(10), 1639-47.
Cholongitas, E., & Pipili C. (2010).  Impact of burnout syndrome on gastroesophageal reflux disease and irritable bowel syndrome in health care workers.. J Clin Psychiatry. 71(2), 209-10.
Cholongitas, E., Goulis J., Arsos G., Birtsou C., Nakouti T., Papadopoulou S., et al. (2013).  Association between ratio of sodium to potassium in random urine samples and renal dysfunction and mortality in patients with decompensated cirrhosis.. Clin Gastroenterol Hepatol. 11(7), 862-7.
Cholongitas, E., Vasiliadis T., Goulis I., Fouzas I., Antoniadis N., Papanikolaou V., et al. (2015).  Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease.. J Viral Hepat. 22(7), 574-80.
Cholongitas, E., Papadakis E., Kaklamanis L., & Dasenaki M. (2009).  Peripheral facial palsy in elderly: not always a benign condition.. Geriatr Gerontol Int. 9(1), 100-1.
Cholongitas, E., Antoniadis N., Goulis I., Fouzas I., Vasiliadis T., Akriviadis E., et al. (2016).  Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.. Liver Transpl. 22(1), 132-3.
Cholongitas, E., Haidich A-B., Apostolidou-Kiouti F., Chalevas P., & Papatheodoridis G. V. (2018).  Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review.. Ann Gastroenterol. 31(4), 480-490.
Cholongitas, E., Shusang V., Germani G., Tsochatzis E., Raimondo M. Luisa, Marelli L., et al. (2011).  Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin.. Clin Transplant. 25(4), 614-24.
Cholongitas, E., Georgousaki C., Spyrou S., Rellos K., & Dasenaki M. (2009).  Staphylococcal pneumonia with multiple muscle abscesses in an immunocompetent patient.. Int J Infect Dis. 13(6), e521.
Cholongitas, E., Senzolo M., Patch D., Shaw S., O'Beirne J., & Burroughs A. K. (2009).  Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality.. Eur J Gastroenterol Hepatol. 21(7), 744-50.
Cholongitas, E. (2009).  Paroxysmal atrial tachycardia associated with prednisolone administration.. J Postgrad Med. 55(4), 316.
Cholongitas, E., Manousou P., Samonakis D., & Burroughs A. K. (2009).  Progression of HCV infection in patients with chronic kidney disease.. J Hepatol. 50(3), 621-2; author reply 622.
Cholongitas, E., Agarwal B., Antoniadis N., & Burroughs A. K. (2012).  Patients with cirrhosis admitted to an intensive care unit.. J Hepatol. 57(1), 230-1; author reply 231-2.
Cholongitas, E., Georgousaki C., Spyrou S., & Dasenaki M. (2010).  Linezolid-induced severe hyperbilirubinemia in a patient with decompensated cirrhosis.. J Infect. 60(2), 182-3.
Cholongitas, E., Calvaruso V., Betrosian A., Senzolo M., Shaw S., O'Beirne J., et al. (2010).  Critically ill patients with cirrhosis and low serum sodium.. J Clin Gastroenterol. 44(7), 523-4; author reply 524-5.
Cholongitas, E., Goulis I., Ioannidou M., Soulaidopoulos S., Chalevas P., & Akriviadis E. (2017).  Urine albumin-to-creatinine ratio is associated with the severity of liver disease, renal function and survival in patients with decompensated cirrhosis.. Hepatol Int. 11(3), 306-314.
Cholongitas, E., Pipili C., & Ioannidou D. (2009).  Malassezia folliculitis presented as acneiform eruption after cetuximab administration.. J Drugs Dermatol. 8(3), 274-5.
Cholongitas, E., Theocharidou E., Vasianopoulou P., Betrosian A., Shaw S., Patch D., et al. (2012).  Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure.. Liver Transpl. 18(4), 405-12.
Chondrou, V., Stavrou E. F., Markopoulos G., Kouraklis-Symeonidis A., Fotopoulos V., Symeonidis A., et al. (2018).  Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea.. Hum Genomics. 12(1), 45.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές